Hari Medi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 1.00 M
as on 17-07-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.42 Cr
as on 17-07-2024
- Satisfied Charges ₹ 11.05 Cr
as on 17-07-2024
- Revenue 31.89%
(FY 2022)
- Profit 24.34%
(FY 2022)
- Ebitda 31.66%
(FY 2022)
- Net Worth 27.03%
(FY 2022)
- Total Assets 24.91%
(FY 2022)
About Hari Medi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.42 Cr. The company has closed loans amounting to ₹11.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Sachdeva, Roopam Sachdeva, Pushpa Sacheva, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232RJ2006PTC022740
- Company No.
022740
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Sriganganagar, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hari Medi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Sachdeva  | Managing Director | 07-Sep-2013 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Roopam Sachdeva | Whole-Time Director | 04-Jul-2006 | Current |
| Pushpa Sacheva | Whole-Time Director | 04-Jul-2006 | Current |
| Hitesh Sachdeva | Whole-Time Director | 04-Jul-2006 | Current |
Financial Performance of Hari Medi Pharma.
Hari Medi Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.89% increase. The company also saw a substantial improvement in profitability, with a 24.34% increase in profit. The company's net worth Soared by an impressive increase of 27.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hari Medi Pharma?
In 2021, Hari Medi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nitya Printpack Private LimitedActive 13 years 11 monthsRoopam Sachdeva and Hitesh Sachdeva are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Mar 2020 | ₹1.42 Cr | Open |
Others Creation Date: 15 Sep 2017 | ₹3.50 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 18 Sep 2014 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Hari Medi Pharma?
Unlock and access historical data on people associated with Hari Medi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hari Medi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hari Medi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
